Pharmaceutical industry – Page 19
-
ArticleContinuous manufacturing could revolutionise drug development
Continuous flow manufacturing of pharmaceuticals offer the flexibility to accelerate the drug development process
-
BusinessCleaning up clinical trials
Campaigns to enforce complete and correct reporting of trial data are beginning to take hold
-
BusinessNovartis to cut over 2000 jobs
Move exemplifies a wave of manufacturing cuts as pharma moves to more high-value, specialised medicines
-
OpinionHas Crispr’s patent battle run its course?
As the originators duke it out in court, their patents are becoming increasingly irrelevant
-
BusinessIndia moves to ban cocktail drugs
Government injunction on 328 fixed dose combinations is strongly opposed by manufacturers
-
-
BusinessLandmark China cancer drug full approval ‘first of a wave’
Chi-Med’s fruquintinib is a result of China’s evolving drug innovation and regulation
-
NewsBitter feuding at Cochrane healthcare audit body paralyses organisation
One member has been expelled from the governing board while another four resign with accusations of pharmaceutical industry bias flying
-
BusinessBuilding resilience to climate threats
As extreme weather events become more frequent, chemical and pharmaceutical producers are taking steps to fend them off in future
-
ResearchGenentech antibiotic quells resistance
Modified arylomycin combines high potency with new mechanism of action
-
BusinessEurope opens gates to CAR-T
First two modified T-Cell cancer therapies approved in the EU, but prices may be prohibitive for public health systems
-
BusinessUS court overturns plant safety rule delay
Appeal finds Trump’s postponement of the 2017 Chemical Disaster Rule was unlawful
-
OpinionFeeding the confusion
When it comes to working out what foods do to our bodies, mostly we just don’t know
-
OpinionBehind enemy lines
When trade war breaks out, globalised industries ship out to dodge tariffs
-
BusinessUS approves first RNA interference drug
Alnylam’s Onpattro (patisiran) can treat a rare hereditary disease by silencing a specific gene
-
BusinessBusinesses use blockchain to take on trustlessness
Big companies are looking to blockchain technology to track transactions, finds Andy Extance, while upstarts exploit its cryptocurrency origins
-
-
BusinessVaccine scandal and heart drug recall show China’s pharma struggles
Fifteen arrests amid evidence of bribery related to vaccines, despite new standards and penalties for fraud
-
BusinessNovartis exit from antibiotics a setback for race against resistance
Experts say business models must change to halt big pharma exodus
-
BusinessTrump coaxes big promises from big pharma
Several drug industry giants are now pledging to freeze price increases in the US, but some suggest the movement is a publicity stunt or worse